Simplify Logo
Roswell Park Comprehensive Cancer Center

Roswell Park Comprehensive Cancer Center

Comprehensive cancer research and treatment center

Assistant/Associate General Counsel - General Counsel & Compliance

Full-Time
$115.3k - $145.7k/yr
Junior, Mid
JD
Buffalo, NY, USA
Hybrid

Hybrid remote work arrangement.

About the job

Requirements
  • Must develop and maintain knowledge of relevant Food and Drug Administration regulations, research subject protection regulations, New York laws applicable to public entities and hospitals, and general health and privacy laws.
  • Assistant General Counsel requires one year of full-time private practice or in-house legal experience.
  • Associate General Counsel requires four years of full-time responsible private practice or in-house legal experience, including general corporate and/or business-related matters.
  • Must hold a Juris Doctor degree from an accredited U.S. law school.
  • Must be admitted to practice law by the State of New York Bar.
Responsibilities
  • Review and negotiate research-related agreements, including clinical trial, subsite/subaward, collaborative research, and sponsored research agreements.
  • Review and negotiate production and manufacturing agreements for investigational cellular therapy products and intermediates, viral and non-viral vectors, and related products.
  • Review and negotiate research-related service agreements and procurement contracts for equipment, reagents, supplies, software, and materials used in production and manufacturing.
  • Handle technology transfer license agreements, commercial collaborations, and other agreements with significant intellectual property implications.
  • Assist with other legal matters supporting the clinical and research missions, including regulatory guidance, contract interpretation, and other requested legal support.
  • Interface with management of clinical, research, and administrative departments and provide timely legal guidance to facilitate organizational objectives and support operations while minimizing legal risk and exposure.
Desired Qualifications
  • For Associate General Counsel, at least three years of experience focusing on relevant areas of law and reviewing or negotiating one or more of the referenced contract types.
  • For Assistant General Counsel, at least one year of experience focusing on relevant areas of law and reviewing or negotiating one or more of the referenced contract types.

About the company

Roswell Park Comprehensive Cancer Center

Roswell Park Comprehensive Cancer Center

View

Roswell Park Comprehensive Cancer Center brings together laboratory research, clinical care, and education in a multidisciplinary environment to advance cancer treatment. Researchers and clinicians work side by side to translate laboratory findings into patient therapies and contribute to ongoing trials, with historical breakthroughs in chemotherapy, photodynamic therapy, and PSA testing. It differentiates itself as the world’s first cancer-focused laboratory, operates as a public benefit corporation owned by New York State, and relies on grants and donations through affiliated nonprofits. The center’s goal is to conquer cancer by coordinating research, clinical care, and education to improve patient outcomes and scientific knowledge.

Company Size

1,001-5,000

Company Stage

Grant

Total Funding

$71.1M

Headquarters

Buffalo, New York

Founded

1898

Get referred to Roswell Park Comprehensive Cancer Center

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • September 14, 2026 EDDY launch expanded lung screening with a compact mobile CT unit.
  • September 9, 2026 Broadview center expansion adds prevention, screening, navigation, and community research space.
  • July-August 2026 grants from Hyundai Hope on Wheels and CDMRP funded pediatric AML and mutant p53 work.

What critics are saying

  • FY2026 audit shows net position fell $46.6 million, while NYS support dropped to $106.8 million.
  • Roswell Park’s FY27 budget still depends on grants, donations, and state funding for workforce costs.
  • If New York trims subsidies again, Roswell Park’s debt-service-backed public model strains payroll and capital.

What makes Roswell Park Comprehensive Cancer Center unique

  • Roswell Park, founded 1898, remains Upstate New York’s only NCI-designated comprehensive cancer center.
  • Its EDDY mobile screening program reached 173 ZIP codes and 72 sites since 2022.
  • International partnerships with Burjeel Medical City and Sethera extend Roswell Park’s protocols and research.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

2%

2 year growth

2%
Roswell Park Comprehensive Cancer Center
Sep 14th, 2026
Roswell Park unveils new EDDY unit to expand access to Lung Cancer Screening and Early Detection.

Roswell Park unveils new EDDY unit to expand access to Lung Cancer Screening and Early Detection. Monday, September 14, 2026 - 03:00 pm New vehicle will bring lifesaving screenings to more neighborhoods, community centers and underserved communities Highlights * More compact unit can navigate narrow streets and smaller parking lots * Over 3,400 lung cancer screenings performed since program launched in 2022 * EDDY program includes a second vehicle for breast and prostate screening BUFFALO, N.Y. - Roswell Park Comprehensive Cancer Center has unveiled a new and more compact mobile lung cancer screening unit, expanding the reach of its Early Detection Driven to You (EDDY) mobile cancer screening program and increasing access to lifesaving cancer screenings throughout Western New York. The new EDDY Mobile Lung Cancer Screening Center, which replaces a vehicle in service since 2022, was engineered for flexibility, allowing it to travel more easily on city streets and operate in community center parking lots, neighborhood gathering spaces and other locations where larger vehicles may be difficult to accommodate. Supported by Roswell Park team members specially trained in Diagnostic Imaging, Cancer Screening and Survivorship, and Community Outreach and Engagement, the EDDY Mobile Cancer Screening Program brings high-quality screening services directly into communities across Western New York. Together with the EDDY Mobile Breast & Prostate Cancer Screening Center debuted last year, this innovative Roswell Park screening program is the first initiative to bring early detection services for the three most common invasive cancers directly into urban and rural communities where screening access may be limited. "Our new EDDY Mobile Lung Cancer Screening Center was designed very intentionally to increase the reach of our incredible outreach and early detection services," said Candace Johnson, PhD, President, CEO and M&T Bank Presidential Chair in Leadership at Roswell Park. "The streamlined design allows us to bring lung cancer screenings to even more neighborhoods, community centers and types of locations making it easier for more people to access potentially lifesaving care." "Screening gives us the opportunity to find lung cancer before symptoms develop, when treatment is often most effective and outcomes can be significantly improved," says Mary Reid, PhD, Chief of Cancer Screening, Survivorship and Mentorship. "This beautiful new mobile screening center will help us reach more individuals in more communities and connect them with potentially lifesaving early detection services. Every screening represents an opportunity to find cancer earlier, intervene sooner and ultimately save lives." Roswell Park held a ribbon-cutting Monday as it unveiled the new mobile unit at the Belle Center on Buffalo's West Side - one of the community centers that has frequently hosted the EDDY Lung and EDDY Breast and Prostate mobile screening centers to make this service available to those it serves. "It is such an honor to work with Roswell Park Comprehensive Cancer Center. It's not only the number one cancer research center in the nation, in my opinion, it's also number one in community service," says Lucy Candelario, Executive Director of the Belle Center. Since launching in 2022, the EDDY Mobile Lung Cancer Screening Center has completed more than 3,400 early detection encounters, reaching patients from 173 ZIP codes. The unit has visited 72 unique locations across 7 counties, including Erie, Cattaraugus, Chautauqua, Allegany, Niagara, Orleans and Broome. Operating 4 days per week in the community, it has partnerships with the Cattaraugus, Tonawanda and Tuscarora tribal territories. It also conducts screenings with 6 fire departments to address occupational exposure risks. More than two dozen screening participants were diagnosed with lung cancer through EDDY screenings, the majority of which were detected at early, more treatable stages. Speaking in Spanish at the event Monday, Evelyn Centeno, a survivor of a previous experience with cancer who has used EDDY mobile cancer screening services three times, said: "Para mí significó mucho que EDDY llegara cerca de mi hogar, a lugares que conocemos en la comunidad. Cuando estos servicios llegan directamente a la comunidad, hacen la vida más fácil para muchas personas. No todo el mundo tiene transportación, puede viajar lejos o puede tomar tanto tiempo fuera del trabajo o de la familia. Por eso, tener a EDDY ahí mismo, cerca de nosotros, ayuda muchísimo." (Translation: "It meant so much to me that EDDY came close to my home, to places we know in the community. When these services come directly into the community, they make life easier for many people. Not everyone has transportation, can travel far, or can take extra time away from work or family. That is why having EDDY right there, close to us, helps so much.") "Roswell Park's expansion of the EDDY program will continue to save lives by bringing screening to more neighborhoods and underserved communities, removing barriers to care and allowing Western New Yorkers to take control of their health," says Congressman Tim Kennedy. "I am grateful for the work and advocacy of everyone at Roswell Park. Their commitment to bringing lifesaving cancer screenings directly into our communities is making a real difference across our region." "Too many families in our community have felt the impact of cancer, which is why programs like EDDY are so incredibly important," says New York State Assemblymember Jon D. Rivera. "By bringing lung cancer screenings directly into neighborhoods, community centers, and underserved areas, Roswell Park is breaking down barriers to care and helping people get screened before it's too late. This new mobile unit reflects Roswell Park's longstanding commitment to innovation and community outreach. I thank Dr. Candace Johnson and the entire Roswell Park team for ensuring that Western New Yorkers have access to the early detection services they need to live healthier lives." Also on hand for the launch event were representatives from USA Mobile Medical, which manufactured the custom 53-foot mobile unit for Roswell Park, and Philips, manufacturer of the specialized low-dose CT (computed tomography) imaging equipment housed in the new mobile screening center - a CT 5300 system equipped with AI-enabled imaging, advanced workflow technologies and AI-based image reconstruction innovation designed to support high quality, low-dose CT imaging. Facts about lung cancer and lung cancer screening: * Lung cancer is the leading cause of cancer deaths in both men and women, causing more deaths than colorectal cancer, pancreatic cancer and breast cancer combined. * Only 24% of these tumors are diagnosed at early stages, when treatment options and expected survival are much more favorable. * Black Americans have a higher risk of developing lung cancer and are 18% less likely than their white counterparts to be diagnosed early. * Based on compelling evidence from large national studies, the U.S. Preventive Services Task Force recommends annual low-dose computed tomography (CT) lung scans for people ages 50-80 who have smoked for at least 20 years. * Earlier this year, the Centers for Medicare & Medicaid Services (CMS) announced a national coverage determination (NCD) that expanded coverage for lung cancer screening to improve health outcomes for people with lung cancer. * More than 36% of New York State residents living in counties with the highest rates of lung cancer deaths must drive at least an hour to get a low-dose CT scan. * Eligibility: You should be screened for lung cancer if you are within the ages of 50 and 79 and have 20 pack/years of smoking history and have smoked within the past 15 years, even if you no longer smoke. You may also be eligible based on personal history of cancer of the lung, esophagus, head or neck, or other factors, including: asbestos-related lung disease or pulmonary asbestosis; history of emphysema; chronic obstructive pulmonary disease (COPD); family history of lung cancer (your parent, sibling or child). * Roswell Park has offered lung cancer screening since 1998 for people who are at high risk of developing the disease. From the world's first chemotherapy research to the PSA prostate cancer biomarker, Roswell Park Comprehensive Cancer Center generates innovations that shape how cancer is detected, treated and prevented worldwide. The Roswell Park team of 4,000+ makes compassionate, patient-centered cancer care and services accessible across New York State and beyond. Rated "Exceptional" by the National Cancer Institute, Roswell Park, founded in 1898, was one of the first NCI-designated comprehensive cancer centers in the country and remains the only one in Upstate New York. To learn more about Roswell Park Comprehensive Cancer Center and the Roswell Park Care Network, visit www.roswellpark.org, call 1-800-ROSWELL (1-800-767-9355) or email [email protected]. Media Contact

Cure Cancer With AI
Aug 15th, 2026
Roswell Park's recognition: implications for cancer care and research.

Roswell Park's recognition: implications for cancer care and research. August 15, 2026 Recently, Roswell Park Comprehensive Cancer Center was honored by Forbes as one of the best employers for women and one of the best in-state employers. This prestigious recognition highlights not only the quality of the workplace environment but also the potential impact on patient care and cancer research. In a field as complex and challenging as oncology, the well-being of healthcare professionals can directly influence the quality of care that patients receive. In this blog post, Cure Cancer With AI will explore the significance of such recognition for cancer patients and the broader implications for the research community. What happened. Forbes evaluated numerous organizations to compile its list of top workplaces, focusing on employee satisfaction, support, and overall happiness. Roswell Park's inclusion in these lists signifies a commitment to cultivating a positive work culture, which is paramount in a high-stress environment like cancer care. A supportive workplace can lead to better collaboration among staff, improved patient interactions, and ultimately, enhanced treatment outcomes. Background: the importance of employee satisfaction in cancer care. The connection between employee satisfaction and patient care is well-documented. When healthcare professionals feel valued and supported, they are more likely to go above and beyond for their patients. In the context of cancer treatment, this can translate to greater attentiveness, empathy, and a holistic approach to patient care. For patients and their families, knowing that the staff at a cancer center is content can foster trust and confidence in the care they will receive. Roswell Park's achievement serves as a reminder that the overall atmosphere within a healthcare facility can significantly affect the patient experience. A positive work culture not only enhances staff morale but also contributes to a more patient-centered approach to care. When healthcare teams work cohesively and supportively, it can lead to better health outcomes, particularly in oncology, where treatment regimens are often complex and multifaceted. How AI fits into cancer research and the path toward better treatments. Artificial intelligence (AI) and machine learning are revolutionizing cancer research and treatment, offering unprecedented opportunities to enhance patient care. While Roswell Park's recognition focuses on employee satisfaction, it also highlights the importance of an environment conducive to innovation. The integration of AI in oncology can lead to more effective diagnostics, personalized treatment plans, and accelerated drug discovery processes. The role of AI in diagnostics. AI technologies are being used to analyze medical imaging and pathology reports more efficiently than traditional methods. By identifying patterns that humans might miss, AI can assist healthcare professionals in making quicker and more accurate diagnoses. This rapid identification is crucial in oncology, where early detection can significantly influence treatment efficacy. Machine learning in drug discovery. In drug discovery, machine learning algorithms can analyze vast datasets to identify potential therapeutic targets and predict how different compounds might behave in the human body. This approach not only speeds up the development of new cancer treatments but also helps researchers understand which patients are likely to benefit from specific therapies, paving the way for precision oncology. AI-Driven patient management. AI is also transforming how healthcare systems manage cancer patients. From tracking treatment progress to predicting patient outcomes, AI tools can enhance the overall patient experience. For instance, predictive analytics can help healthcare providers identify which patients might need additional support, ensuring that care is tailored to individual needs. What patients and readers should know. For cancer patients and their families, understanding the implications of workplace satisfaction at cancer centers like Roswell Park is vital. A supportive environment for healthcare providers can lead to improved patient care, which is essential in the context of cancer treatment. As patients navigate their journeys, knowing that they are being cared for by satisfied and engaged professionals can offer peace of mind. Furthermore, staying informed about advancements in cancer research and the role of AI can empower patients and their families. Resources like curecancerwithai.com provide a centralized platform for exploring how artificial intelligence is being used in oncology, keeping patients and advocates updated on the latest news and developments in cancer research. This knowledge can help families make more informed decisions about their care and understand the potential benefits of emerging treatments. Conclusion. The recognition of Roswell Park as one of the best employers underscores the importance of a supportive workplace in the field of oncology. As cancer treatment continues to evolve with the integration of artificial intelligence and machine learning, the implications for patient care are profound. By fostering an environment where healthcare professionals feel valued, Cure Cancer With AI can ensure that patients receive the highest standard of care. For those interested in learning more about how AI is transforming cancer research and treatment, curecancerwithai.com offers valuable insights and resources to stay informed.

Newswise
Aug 14th, 2026
Roswell Park named to Best Employers for Women and Best In-State Employers lists.

Roswell Park named to Best Employers for Women and Best In-State Employers lists. Cancer center ranked on national lists by Forbes. Highlights * Women's list based on surveys from more than 146,000 women * Roswell Park ranked as top healthcare organization in state employers list * Also recognized as one of America's Best Employers for Company Culture Newswise - BUFFALO, N.Y. - Roswell Park Comprehensive Cancer Center has been named by Forbes to its lists of America's Best Employers for Women and America's Best In-State Employers. Working with market research firm Statista to rank the companies, Forbes announced both lists this month. For its Best Employers for Women list, Forbes and Statista surveyed more than 146,000 women working for companies that employ at least 1,000 people in the United States. Participants were asked to rate their current employers in areas such as pay equity, career development, parental leave, work-life balance, benefits for childcare or eldercare, and the company's handling of incidents related to sexual misconduct or discrimination. Statista also researched the percentage of women in executive and board positions at each company. Roswell Park is the only Western New York healthcare organization on the list of 700 companies. Roswell Park was also recognized on Forbes' Best Employers by State listing, ranked as the top healthcare organization in New York and in the top 15 among overall employers. This is the fifth consecutive year that Roswell Park has made the list. For it, Statista surveyed more than 245,000 employees who work for a company of at least 500 people in the country. Survey respondents were asked how likely they were to recommend their employer on a scale of zero to 10 on topics such as wages and benefits, management style, company reputation, flexibility and career advancement. Earlier this year, Roswell Park was named to Forbes list of America's Best Employers for Company Culture and Newsweek's list of World's Best Specialized Hospitals. See the full list of America's Best Employers for Women here and America's Best In-State Employers here. Media contact. Type of article. Section.

50 States Today
Aug 10th, 2026
Sethera Therapeutics' polymacrocyclic peptide platform selected for cdmrp-supported Mutant p53 Breast Cancer program.

Sethera Therapeutics' polymacrocyclic peptide platform selected for cdmrp-supported Mutant p53 Breast Cancer program. SALT LAKE CITY, UT, UNITED STATES, August 10, 2026 /EINPresswire.com/ - Salt Lake City, UT - August 10th, 2026 - Sethera Therapeutics announced that a collaborative breast cancer research project with Roswell Park Comprehensive Cancer Center has received funding through the Fiscal Year 2025 Breast Cancer Research Program Breakthrough Award, administered by the Congressionally Directed Medical Research Programs (CDMRP). The award supports innovative, high-impact research aimed at advancing the prevention, diagnosis, and treatment of breast cancer. The project reflects CDMRP's commitment to accelerating transformative discoveries that may improve outcomes for individuals affected by breast cancer. The award recognizes the scientific merit, innovation, and collaborative strength of the research teams led by Dr. Katerina Gurova at Roswell Park Comprehensive Cancer Center and Dr. Karsten Eastman at Sethera Therapeutics. Sethera Therapeutics has developed a polymacrocyclic peptide (pMCP) discovery platform designed to discover and engineer constrained peptide molecules with differentiated architectures and chemistries. The technology was first developed at the University of Utah with NIH support and licensed exclusively to Sethera Therapeutics. The pMCP platform offers a new approach for pursuing difficult biological targets that have been challenging for conventional drug modalities. Polymacrocyclic Peptides for Mutant p53-Driven Breast Cancer The collaborative breast cancer project focuses on one of the most common and difficult problems in cancer biology: mutations in p53, a protein often described as the "guardian of the genome." In healthy cells, p53 helps prevent damaged cells from continuing to grow. In many cancers, including aggressive breast cancers, p53 becomes mutated and loses this protective function. These mutant forms of p53 can adopt abnormal conformations that allow cancer cells to survive, divide, and resist treatment. Sethera will use its polymacrocyclic peptide platform to discover constrained peptide molecules that bind mutant p53 and stabilize conformations associated with restored tumor-suppressive activity. Rather than simply blocking a cancer target, the goal is to identify molecules capable of modulating mutant p53 structure and function in ways that are difficult to achieve with conventional modalities. This approach could support a new therapeutic strategy for breast cancers driven by p53 mutations, including forms of the disease that currently have limited targeted treatment options. "This program represents an important external validation of both our platform and our strategy of applying architecture-diverse peptides to targets that have remained beyond the practical reach of many established drug classes," said Karsten Eastman, PhD, CEO of Sethera Therapeutics. "Mutant p53 is an especially compelling test because its biological activity is closely linked to its three-dimensional structure. By working with Dr. Gurova and the Roswell Park team, we can evaluate not only whether our molecules bind mutant p53, but whether they can produce meaningful functional rescue in disease-relevant systems." The Breast Cancer Research Program Breakthrough Award is designed to support promising and innovative studies that challenge existing paradigms and accelerate progress in breast cancer research. The FY25 award underscores the federal government's continued investment in transformative medical research and scientific collaboration. About Sethera Therapeutics Sethera Therapeutics is a biotechnology company developing a polymacrocyclic peptide discovery platform based on enzymatic cross-linking chemistry. The platform enables the generation and screening of highly constrained peptide architectures designed to access chemical and biological space that is difficult to reach with conventional small molecules, biologics, or traditional peptide approaches. Sethera's technology was originally developed at the University of Utah and is exclusively licensed to the company. By collaborating with industry leaders and research institutions, Sethera aims to unlock new possibilities in drug discovery and development for targets that are difficult to address with existing therapeutic modalities. For more information about partnering with Sethera, visit setheratx.com. Karsten Eastman Sethera Therapeutics, Inc. +1 8018504367 email 50 States Today here Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. 50 States Today do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Roswell Park Comprehensive Cancer Center
Jul 23rd, 2026
Hyundai Hope on Wheels awards $100,000 to Roswell Park to fund CAR t-cell research for children with AML.

Hyundai Hope on Wheels awards $100,000 to Roswell Park to fund CAR t-cell research for children with AML. Thursday, July 23, 2026 - 03:45 pm National nonprofit hits $1 million in lifetime giving to Roswell Park Highlights * Dr. David Byrwa receives $100,000 from Hyundai Hope on Wheels (HHOW). * The grant supports the research of CAR T-cell therapy for children with AML * This marks the tenth grant Roswell Park has received from HHOW. BUFFALO, NY - Hyundai Hope On Wheels(R)(HHOW), a 501(c)(3) nonprofit organization supported by Hyundai Motor America and its U.S. dealers, awarded a $100,000 Hyundai Impact Award Grant to Roswell Park Comprehensive Cancer Center to continue its long-standing commitment to advancing pediatric cancer. The Hyundai Impact Award was presented to David Byrwa, MD, at Roswell Park on Thursday to support research into CAR T-cell therapy for children with relapsed or treatment-resistant acute myeloid leukemia (AML). Dr. Brywa works in the Department of Pediatric Oncology at Roswell Park. 14-year-old Kienen Duggan, a pediatric patient at Roswell Park, shared her cancer story. Kienen was diagnosed with AML last August. She underwent chemotherapy and a bone marrow transplant - with her sister being the donor. "Through it all, I knew I could rely on my doctors here at Roswell Park. One of them was Dr. Dave [Brywa]. He has been there since the beginning," said Kienen. "I always had faith and trust in my doctors at Roswell Park. For every up and down, my doctors were always there rooting for me and cheering me on every step of the way." Keinen has been declared cancer free and rang the Victory Bell at Roswell Park on April 24. This grant through Hyundai Hope on Wheels supports the development of a promising new CAR T-cell therapy for children with limited treatment options. "Our goal is to bring promising discoveries from the laboratory to the children who need them most. This grant allows us to take an important step toward evaluating a new CAR T-cell therapy that has the potential to improve outcomes for pediatric AML patients," said Dr. Byrwa. "Support like this from Hyundai Hope on Wheels makes it possible to move innovative ideas into clinical trials. We're hopeful this research will lead to safer, more effective treatments for children facing relapsed or treatment-resistant AML." With this latest grant, Hyundai Hope on Wheels has reached $1 million in lifetime giving to Roswell Park. "This milestone is a powerful reminder that meaningful progress in pediatric cancer research is built in part through sustained partnerships," said Dr. Kara Kelly, chair of the Department of Pediatric Oncology at Roswell Park. "Hyundai Hope on Wheels' continued investment enables us to ask bigger questions, pursue innovative therapies and, ultimately, give more children the opportunity to live longer, healthier lives." Since 1998, Hyundai Hope on Wheels has worked tirelessly to support the families, researchers, doctors, and children affected by childhood cancer. To date, Hyundai Hope on Wheels has awarded grants totaling more than $303 million, thanks to Hyundai Motor America and its nationwide dealers. Through these partnerships, Hyundai Hope on Wheels continues to advance research and bring hope to families affected by childhood cancer. "Advancing pediatric cancer research requires bold science and sustained commitment," said John Guastaferro, executive director, Hyundai Hope on Wheels. "We are deeply grateful to Roswell Park Comprehensive Cancer Center and its doctors and researchers whose dedication drives progress to the children and families who need it most." About Hyundai Hope on Wheels Hyundai Hope on Wheels(R) is a 501(c)(3) nonprofit organization that is committed to finding a cure for childhood cancer. Launched in 1998, Hyundai Hope on Wheels provides grants to eligible institutions nationwide that are pursuing critical research aimed at improving treatments and saving lives. Hyundai Hope on Wheels is one of the largest nonprofit funders of pediatric cancer research in the country. Primary funding for Hyundai Hope on Wheels comes from Hyundai Motor America and its more than 830 U.S. dealers. In 2025, Hyundai Hope on Wheels awarded over $27 million in pediatric cancer research grants to hospitals throughout the United States. About Hyundai Motor America Hyundai Motor America offers U.S. consumers a technology-rich lineup of cars, SUVs, and electrified vehicles, while supporting Hyundai Motor Company's Progress for Humanity vision. Hyundai has significant operations in the U.S., including its North American headquarters in California, the Hyundai Motor Manufacturing Alabama assembly plant, the all-new Hyundai Motor Group Metaplant America (in development in Georgia), and several cutting-edge R&D facilities. These operations, combined with those of Hyundai's 835 independent dealers, contribute $20.1 billion annually and 190,000 jobs to the U.S. economy, according to a recent economic impact report. For more information, visit www.hyundainews.com. About Roswell Park From the world's first chemotherapy research to the PSA prostate cancer biomarker, Roswell Park Comprehensive Cancer Center generates innovations that shape how cancer is detected, treated and prevented worldwide. The Roswell Park team of 4,000+ makes compassionate, patient-centered cancer care and services accessible across New York State and beyond. Rated "Exceptional" by the National Cancer Institute, Roswell Park, founded in 1898, was one of the first NCI-designated comprehensive cancer centers in the country and remains the only one in Upstate New York. To learn more about Roswell Park Comprehensive Cancer Center and the Roswell Park Care Network, visit www.roswellpark.org, call 1-800-ROSWELL (1-800-767-9355) or email [email protected]. About the Roswell Park Alliance Foundation The Roswell Park Alliance Foundation is a is a 501(c)(3) not-for-profit organization that manages all donations made to Roswell Park Comprehensive Cancer Center. Its mission is to maximize dollars available for Roswell Park Comprehensive Cancer Center's most promising lifesaving research, treatment and prevention programs, while supporting the psychosocial needs of patients and families touched by cancer. To learn more about the Roswell Park Alliance Foundation and the research and patient care programs it supports at Roswell Park, visit https://roswellparkalliancefoundation.org/. Media Contact Jackie McDonough, Communications Manager Roswell Park Alliance Foundation [email protected]